| Literature DB >> 23265866 |
Jaime Gómez-Laguna1, Francisco J Salguero, Francisco J Pallarés, Librado Carrasco.
Abstract
Porcine reproductive and respiratory syndrome (PRRS) virus (PRRSV) impairs local pulmonary immune responses by damaging the mucociliary transport system, impairing the function of porcine alveolar macrophages andinducing apoptosis of immune cells. An imbalance between pro- and anti-inflammatory cytokines, including tumour necrosis factor-α and interleukin-10, in PRRS may impair the immune response of the lung. Pulmonary macrophage subpopulations have a range of susceptibilities to different PRRSV strains and different capacities to express cytokines. Infection with PRRSV decreases the bactericidal activity of macrophages, which increases susceptibility to secondary bacterial infections. PRRSV infection is associated with an increase in concentrations of haptoglobin, which may interact with the virus receptor (CD163) and induce the synthesis of anti-inflammatory mediators. The balance between pro- and anti-inflammatory cytokines modulates the expression of CD163, which may affect the pathogenicity and replication of the virus in different tissues. With the emergence of highly pathogenic PRRSV, there is a need for more information on the immunopathogenesis of different strains of PRRS, particularly to develop more effective vaccines.Entities:
Mesh:
Year: 2012 PMID: 23265866 PMCID: PMC7128372 DOI: 10.1016/j.tvjl.2012.11.012
Source DB: PubMed Journal: Vet J ISSN: 1090-0233 Impact factor: 2.688
Fig. 2Proposed immunopathogenesis of porcine reproductive and respiratory syndrome virus (PRRSV) and secondary bacterial infection in the lung. PAMs, pulmonary alveolar macrophages; Hp, haptoglobin; IL-10, interleukin-10; TGF-β, transforming growth factor-β.
Cytokines examined in porcine reproductive and respiratory syndrome (PRRS) and their role in the immunopathogenesis of the disease.
| Cytokine | Role in PRRS | References |
|---|---|---|
| IL-1 | Chemotaxis of monocytes and neutrophils | |
| Early upregulation in BALF and in the lung parenchyma | ||
| Poor and delayed enhancement in serum | ||
| IL-6 | Induction of acute phase proteins | |
| Upregulation in situ in the lung parenchyma | ||
| TNF-α | Inhibition of PRRSV replication | |
| Induction of acute phase proteins | ||
| Downregulated in PRRSV-infected PAMs | ||
| IFN-α | Correlation between virus specific IFNα-SCs and IFNγ-SCs | |
| Interference with PRRSV replication | ||
| Downregulation in PRRSV-infected PAMs and/or PBMCs | ||
| IFN-γ | Inhibition PRRSV replication | |
| Enhancement by PRRSV vaccination with IL-12 or IFN-α | ||
| Delayed onset of PRRSV specific IFNγ-SCs | ||
| Higher expression with highly virulent PRRSV strains | ||
| IL-10 | Correlation with the expression of PRRSV in the lung | |
| Inhibition of the expression of IFN-γ and other cytokines | ||
| TGF-β | Induction of regulatory T cells after PRRSV-2 infection | |
| Correlation with the expression of PRRSV in the lung | ||
IL, interleukin; BALF, bronchoalveolar lavage fluid; TNF, tumour necrosis factor; PRRSV, porcine reproductive and respiratory syndrome virus; PAMs, porcine alveolar macrophages; IFN, interferon; SC, secreting cells; PBMCs, peripheral blood mononuclear cells; TGF, transforming growth factor; PRRSV-2, porcine reproductive and respiratory syndrome virus type 2.
Fig. 1Immune regulation associated with the expression and/or inhibition of tumour necrosis factor (TNF)-α and interleukin (IL)-10 during porcine reproductive and respiratory syndrome virus (PRRSV) infection.
Mediators involved in regulation of CD163 receptor.
| Mediator | Upregulation | Downregulation | References |
|---|---|---|---|
| IL-6 | + | − | |
| IL-10 | + | − | |
| M-CSF | + | − | |
| Hb–Hp complexes | + | − | |
| Dexamethasone | + | − | |
| TNF-α | − | + | |
| IFN-γ | − | + | |
| TGF-β | − | + | |
| GM-CSF+IL-4 | − | + | |
| Lipopolysaccharide | − | + | |
| 12-O-tetradecanoylphorbol-13-acetate | − | + |
IL, interleukin; M-CSF, macrophage colony-stimulating factor; HB–Hp, haemoglobin–haptoglobin; TNF, tumour necrosis factor; IFN, interferon; TGF, transforming growth factor; GM-CSF, granulocyte macrophage colony-stimulating factor.